Neoadjuvant dabrafenib and trametinib for functional organ preservation in recurrent BRAF V600E-mutated papillary thyroid cancer
Janice L. Farlow(Indiana University Health), Amit Agrawal(Massachusetts Institute of Technology), Jennifer A. Sipos(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Bhavana Konda(The Ohio State University), Hilary C. McCrary(University of Utah), John E. Phay(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 11
Related Papers
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|514
Nonacid Reflux in Patients With Chronic Cough on Acid-Suppressive Therapy
|CHEST Journal|2006|186
Lessons Learned from Whole Exome Sequencing in Multiplex Families Affected by a Complex Genetic Disorder, Intracranial Aneurysm
|PLoS ONE|2015|141
The role of same-sex mentorship and organizational support in encouraging women to pursue surgery
|The American Journal of Surgery|2017|122
Whole-Exome Sequencing in Familial Parkinson Disease
|JAMA Neurology|2015|79